Related Experiment Videos
Contemporary pulmonary embolism thrombolysis
1Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
International Journal of Cardiology
|August 26, 1998
Summary
Pulmonary embolism treatment involves thrombolysis for clot removal and anticoagulation for prevention. Echocardiography risk-stratifies patients, guiding treatment decisions for better outcomes.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Medical Imaging
Background:
- Pulmonary embolism (PE) management requires differentiating between primary treatment and secondary prevention strategies.
- Risk assessment is crucial for determining optimal patient management and preventing adverse clinical outcomes.
Purpose of the Study:
- To evaluate the role of echocardiography in risk-stratifying patients with pulmonary embolism.
- To guide the selection of appropriate treatment strategies, including thrombolysis and anticoagulation.
Main Methods:
- Utilized echocardiography to assess right ventricular function in patients with pulmonary embolism.
- Correlated echocardiographic findings with patient prognosis and risk of recurrent events.
Main Results:
- Normal right ventricular function indicates a favorable prognosis with anticoagulation alone.
- Right ventricular hypokinesis or dilatation suggests a high risk of recurrent PE despite anticoagulation.
- Thrombolysis effectively reverses right heart failure in high-risk PE patients, proving life-saving.
Conclusions:
- Echocardiography is a valuable tool for risk stratification in pulmonary embolism.
- Tailoring treatment based on right ventricular function optimizes patient care and outcomes.
- Streamlined thrombolytic therapy improves efficacy, safety, and cost-effectiveness for high-risk PE patients.